Abstract
In the absence of effective treatment, infection with the human immunodeficiency virus (HIV) ultimately leads to the acquired immune deficiency syndrome (AIDS). Many attempts have been made to prevent and attenuate HIV infection. While antiretroviral therapies for infected individuals have had great success, preventative and therapeutic vaccines focused on both humoral and cell-mediated immunity have failed. Recently, several natural killer cell receptor (NKR) genotypes, in concert with certain class I human histompatibility-linked antigens (HLA) were found to be associated with protection from HIV infection and/or disease progression. These receptors are expressed on both natural killer (NK) cells and subsets of T lymphocytes. As HIV infection is often associated with attenuation of NK cells and much remains unknown about the basic functions of NKR, it remains undetermined whether the protective effect of these receptors relates to their expression on NK cells, T lymphocytes or both. This review summarizes current literature regarding NKR and HIV infection, and addresses several major questions remaining about the role of these receptors in protection against infection and disease progression.
Keywords: NK cells, HIV, T lymphocytes, NK receptors, AIDS
Current HIV Research
Title: Natural Killer Cell Receptors in Human Immunodeficiency Virus Infection: Pathways to Protection or Doors to Disappointment?
Volume: 7 Issue: 5
Author(s): Matthew S. Parsons and Michael Grant
Affiliation:
Keywords: NK cells, HIV, T lymphocytes, NK receptors, AIDS
Abstract: In the absence of effective treatment, infection with the human immunodeficiency virus (HIV) ultimately leads to the acquired immune deficiency syndrome (AIDS). Many attempts have been made to prevent and attenuate HIV infection. While antiretroviral therapies for infected individuals have had great success, preventative and therapeutic vaccines focused on both humoral and cell-mediated immunity have failed. Recently, several natural killer cell receptor (NKR) genotypes, in concert with certain class I human histompatibility-linked antigens (HLA) were found to be associated with protection from HIV infection and/or disease progression. These receptors are expressed on both natural killer (NK) cells and subsets of T lymphocytes. As HIV infection is often associated with attenuation of NK cells and much remains unknown about the basic functions of NKR, it remains undetermined whether the protective effect of these receptors relates to their expression on NK cells, T lymphocytes or both. This review summarizes current literature regarding NKR and HIV infection, and addresses several major questions remaining about the role of these receptors in protection against infection and disease progression.
Export Options
About this article
Cite this article as:
Parsons S. Matthew and Grant Michael, Natural Killer Cell Receptors in Human Immunodeficiency Virus Infection: Pathways to Protection or Doors to Disappointment?, Current HIV Research 2009; 7 (5) . https://dx.doi.org/10.2174/157016209789346273
DOI https://dx.doi.org/10.2174/157016209789346273 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
Call for Papers in Thematic Issues
Management of HIV: Management of HIV: old challenges and new needs
The aim of this thematic issue is to provide the most recent updates regarding the effective management of HIV infection. Antiretroviral therapy (ART) has significantly decreased HIV-related mortality, leading to an enhancement in the quality of life and life expectancy for people living with HIV (PLWH). Despite the numerous advancements ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacogenomics of Breast Cancer Targeted Therapy: Focus on Recent Patents
Recent Patents on DNA & Gene Sequences CAM Use in Pediatric Oncology
Current Pediatric Reviews A Review of Fish Lectins
Current Protein & Peptide Science Novel Drug-Induced Pulmonary Complications in Cancer Patients You Can Save Life!
Current Respiratory Medicine Reviews Intracellular Logistics of BST-2/Tetherin
Current HIV Research Protein Kinases as Tumor Biomarkers and Therapeutic Targets
Current Pharmaceutical Design Cyclodextrins for Non-Viral Gene and siRNA Delivery
Pharmaceutical Nanotechnology Mouse Models of Autoimmune Uveitis
Current Pharmaceutical Design Naturally Plant-Derived Compounds: Role in Bone Anabolism
Current Molecular Pharmacology pH-Sensitive PEGylated Liposomes Functionalized With a Fibronectin-Mimetic Peptide Show Enhanced Intracellular Delivery to Colon Cancer Cells
Current Pharmaceutical Biotechnology Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer
Current Medicinal Chemistry Understanding the Interaction Between Human Serum Albumin and Anti-Bacterial/ Anti-Cancer Compounds
Current Pharmaceutical Design Potential Role of <i>In Vitro-In Vivo</i> Correlations (IVIVC) for the Development of Plant-Derived Anticancer Drugs
Current Drug Targets Inverse Regulation of MMP-9 and MMP-2 in Long-Term Follow-up After Acute Coronary Syndrome: Lack of Correlation with Platelet and Endothelial Cell Activation Markers
Vascular Disease Prevention (Discontinued) Molecular Mechanisms of Tumor Invasion and Metastasis: An Integrated View
Current Molecular Medicine Recent Studies on Macromolecular Synthesis Labeled with 3H-Thymidine in Various Organs as Revealed by Electron Microscopic Radioautography
Current Radiopharmaceuticals Engineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective
Current Pharmaceutical Design IgG4-Related Disease (IgG4+MOLPS) – Diagnostic Criteria and Diagnostic Problems
Current Immunology Reviews (Discontinued) Targeting Angiogenesis in Renal Cell Carcinoma
Current Cancer Drug Targets Review of Selected Patents for Cancer Therapy Targeting Tumor Angiogenesis
Recent Patents on Anti-Cancer Drug Discovery